Ligustrazine Phosphate and Sodium Chloride Injection
Function and Efficacy
This product has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic.
Ingredients
Ligustrazine phosphate
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LigustrazinePhosphateIngredients |
It has the effects of anti-platelet aggregation, dilation of arterioles, and improvement of microcirculation. Animal experiment results show that this product is non-irritating, non-allergic, and non-hemolytic. More |
848645-86-3 | 6 |
Appearance
This product is a colorless or almost colorless clear liquid.
Indication
Used for ischemic cerebrovascular diseases, such as cerebral ischemia, cerebral thrombosis, and cerebral infarction.
Usage and Dosage
Intravenous drip. 50-100 mg once a day, slowly drip, preferably within 3-4 hours. 10-15 days as a course of treatment, or follow the doctor's advice.
Adverse Reactions
Occasionally, stomach discomfort, dry mouth, and drowsiness may occur; reducing the dosage may alleviate occasional allergic reactions.
Precautions
1. Patients with a history of allergy to any ingredient in this product are prohibited from using this product. 2. Patients with cerebral hemorrhage or bleeding tendency are prohibited from using this product.
Drug Interactions
This product is highly acidic and is not suitable for use with alkaline drugs.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
100ml: 100mg of ligustrazine phosphate and 0.9g of sodium chloride
Manufacturer
Jilin PROVINCE Changyuan Pharmacy Company Limited
-
Founded in:
2001-11-23 -
Address:
No. 1199, Jinhu Road, Changchun High-tech Development Zone -
Tax NO.:
91220101727119002D -
Registered Funds:
30 million yuan -
Website:
-
Email: